Main Article Content

Muhammad Syafiq bin Mohammad Isa Wan Ahmad Syahril Rozli Wan Ali

Abstract

Calciphylaxis is a vascular calcification disease causing skin necrosis which contributes to high morbidity and mortality. Its exact pathogenesis is currently unknown but is commonly associated with chronic renal failure, hypercalcemia, hyperphosphatemia, secondary hyperparathyroidism and a variety of hypercoagulable state. It is relatively rare but may occur in 1-4% of patients with End Stage Renal Failure (ESRF).1 We are reporting a case of young lady with underlying ESRF presented with vascular and skin calciphylaxis.

Downloads

Download data is not yet available.

Article Details

How to Cite
Mohammad Isa, M. S. bin ., & Wan Ali, W. A. S. R. . (2023). Severe Calciphylaxis Secondary to end Stage Renal Failure: A Case Report. Medical and Health Science Journal, 7(02), 39–43. https://doi.org/10.33086/mhsj.v7i02.4639
Section
Articles
calciphylaxis, end stage renal failure

References

Angelis, M., Wong, L. L., Myers, S. A., & Wong, L. M. (1997). Calciphylaxis in patients on hemodialysis: a prevalence study. Surgery, 122(6), 1083–1090. https://doi.org/10.1016/s0039-6060(97)90212-9

Fader DJ, Kang S. Calciphylaxis Without Renal Failure. Arch Dermatol. 1996;132(7):837–838. doi:10.1001/archderm.1996.03890310129026

Weenig, R. H., Sewell, L. D., Davis, M. D., McCarthy, J. T., & Pittelkow, M. R. (2007). Calciphylaxis: natural history, risk factor analysis, and outcome. Journal of the American Academy of Dermatology, 56(4), 569–579. https://doi.org/10.1016/j.jaad.2006.08.065

Baby, D., Upadhyay, M., Joseph, M. D., Asopa, S. J., Choudhury, B. K., Rajguru, J. P., & Gupta, S. (2019). Calciphylaxis and its diagnosis: A review. Journal of family medicine and primary care, 8(9), 2763–2767. https://doi.org/10.4103/jfmpc.jfmpc_588_19

Cicone, J. S., Petronis, J. B., Embert, C. D., & Spector, D. A. (2004). Successful treatment of calciphylaxis with intravenous sodium thiosulfate. American journal of kidney diseases : the official journal of the National Kidney Foundation, 43(6), 1104–1108. https://doi.org/10.1053/j.ajkd.2004.03.018

Ning, M. S., Dahir, K. M., Castellanos, E. H., & McGirt, L. Y. (2013). Sodium thiosulfate in the treatment of non-uremic calciphylaxis. The Journal of dermatology, 40(8), 649–652. https://doi.org/10.1111/1346-8138.12139

Colette B. Raymond., Lori D. W. (2008). Sodium thiosulfate, bisphosphonates, and cinacalcet for treatment of calciphylaxis, American Journal of Health-System Pharmacy, Volume 65, Issue 15, Pages 1419–1429, https://doi.org/10.2146/ajhp070546

Muhammad Syafiq bin Mohammad Isa, Kulliyyah of Medicine, International Islamic University Malaysia

Wan Ahmad Syahril Rozli Wan Ali